Parkinson's Disease Clinical Trial
Official title:
The Role of Somatosensory Dysfunction as the Underlying Mechanism of Upper Limbs Motor Blocks in People With Parkinson's Disease With and Without Freezing of Gait
Verified date | August 2017 |
Source | Katholieke Universiteit Leuven |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Motor blocks during gait and upper limb movements (FOULs) are a disabling and common motor
impairment in mild to severe stages of Parkinson's disease (PD). However, the main mechanism
underlying these phenomena is still an open debate. Apart from the motor correlates,
cognitive-attentional impairment and somatosensory deficits (especially in the proprioceptive
system) may underlie these motor blocks. The current study aims to unravel whether the
proprioceptive system is involved by manipulating task-relevant or non-relevant
proprioceptive stimuli.
Hence, the main aims of this study are:
(i) to assess the somatosensory function in people with PD that experience freezing of gait
FOG and (ii) to investigate the effects of manipulating both proprioception and attentional
resources on FOUL severity.
Forty-five people will be assigned to three age-matched groups (N=15 each): healthy elderly,
PD patients that experience FOG (FOG+) and PD patients that do not experience FOG. Cutaneous
sensory function and kinesthetic ability will be assessed by means of standardized
user-friendly methods and precise repositioning measures using the VICON motion analysis.
Additionally, participants will perform a newly developed task that can successfully elicit
FOULs (a handwriting freezing-provoking task) on a custom tablet (Heremans et al 2015). The
task will be performed without and with the use of muscle vibration (a well-known method to
stimulate the proprioceptive system). The investigators will manipulate both the timing of
vibration (relevant - after FOUL onset; or non-relevant: before FOUL onset) and the region of
stimulation (neutral: on a bone-mark where there is little if any proprioceptive stimulation;
and on a non-neutral spot: on the forearm muscles). It is believed that FOG+ will present
with worse somatosensory function than those who do not experience motor blocks (especially
in the proprioceptive system). Additionally, the Investigators expect a reduction in FOUL
severity (e.g. FOUL duration) when vibration is applied in a task-relevant way, independently
of the region stimulated. In contrast, it is also expected that when vibration is applied in
a non-relevant way and it may act as a distractor, FOUL duration will increase. This study
will thus be able to distinguish between the contribution of attentional and proprioceptive
resources to the mechanism of motor blocks in PD.
Status | Completed |
Enrollment | 45 |
Est. completion date | July 2016 |
Est. primary completion date | March 2016 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - PD patients (N=30): - Diagnosis of PD based on the UK PD brain bank criteria - Hoehn & Yahr stage II-III (ON-medication) Exclusion Criteria: - Cognitive dysfunction Score on the Mini Mental State Examination (MMSE) < 23/30 - Medication change in the past 1 month - Other neurological disorders - Vestibular disorder - Uncontrolled diabetes - Cutaneous diseases - Left-handedness |
Country | Name | City | State |
---|---|---|---|
Belgium | CatholicULeuven | Leuven |
Lead Sponsor | Collaborator |
---|---|
Katholieke Universiteit Leuven | Conselho Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior. |
Belgium,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in upper limb motor blocks duration | 30 min | ||
Primary | Joint Position Sense | Participants will be comfortably seated, while both forearms rest on a table with hands facing down. Then, the right arm should slowly and actively be moved to a certain target angle indicated by the test leader. This target angle should be memorized while holding their arm at this position for 4s, after which participants slowly return their arm to the starting position. After 3s, participants will be asked to actively reproduce the previous target position with the same limb. All trials will be conducted while participants maintain their eyes closed and with their elbow off the table surface. The limb position will be recorded by using 7 MX-T20 optoelectronic cameras (Vicon, Oxford Metrics, UK). For this 3D movement analysis, each participant will be instrumented with 10 spherical reflective markers positioned on participants' right shoulder, arm, elbow, forearm and hand. | 15 min | |
Primary | Perceptual Threshold of Touch | For this test a dual channel nerve stimulator (TENS) will be used (CEFAR PRIMO PRO - CEFAR Medical AB®). Participants will be seated in a standardized and comfortable way, allowing them to observe the entire procedure. Two individual electrodes (3cm of diameter) will be placed on bulb of the index finger (anode) and on the tenar region of the same limb (cathode). A constant current of 40Hz with single square pulses with 80µs of duration will be used. The current amplitude will be increased in steps of 0.5mA at every 2 seconds. The participant will be instructed to say "now" when they feel a slight tingling sensation. Three trials will be used for both hands. The Perceptual Threshold of Touch will be considered as the average of the three trials. It is expected that subjects will feel a slight itching and painless sensation. To avoid any discomfort, the test will be interrupted whenever an involuntary movement is seen, since the Motor Threshold always precedes the Pain Threshold. | 15 min | |
Secondary | Writing amplitude assessed by a tablet | The paradigm consists of performing a task on a 16.5cm length tablet (Fujitsu Componentes Europe®) .The device is powered by a regular laptop. To maximize participants' comfort the tablet screen is squared. The task consists of a 'freezing-provoking task'. This 'freezing-provoking' task has already been tested in people with PD in a current writing study at the Neuromotor Research Group . This task has been shown to be highly successful to elicit motor blocks in the upper limbs in PD patients (data submitted for publication). Each trial will last 30 seconds and as much trials as needed will be provided before the data collection to ensure participants have learned the task. | 30 min | |
Secondary | Somatosensory Function | Assessed by the Erasmus Notthingham Sensory Assessment (EmNSA) | 30 min |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02915848 -
Long-term Stability of LFP Recorded From the STN and the Effects of DBS
|
||
Recruiting |
NCT03648905 -
Clinical Laboratory Evaluation of Chronic Autonomic Failure
|
||
Terminated |
NCT02688465 -
Effect of an Apomorphine Pump on the Quality of Sleep in Parkinson's Disease Patients (POMPRENELLE).
|
Phase 4 | |
Completed |
NCT05040048 -
Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease
|
||
Active, not recruiting |
NCT04006210 -
Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations
|
Phase 3 | |
Completed |
NCT02562768 -
A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease
|
Phase 1 | |
Completed |
NCT00105521 -
Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia
|
Phase 3 | |
Completed |
NCT00105508 -
Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia
|
Phase 3 | |
Recruiting |
NCT06002581 -
Repetitive Transcranial Magnetic Stimulation(rTMS) Regulating Slow-wave to Delay the Progression of Parkinson's Disease
|
N/A | |
Completed |
NCT02236260 -
Evaluation of the Benefit Provided by Acupuncture During a Surgery of Deep Brain Stimulation
|
N/A | |
Completed |
NCT00529724 -
Body Weight Gain, Parkinson, Subthalamic Stimulation
|
Phase 2 | |
Active, not recruiting |
NCT05699460 -
Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy
|
||
Completed |
NCT03703570 -
A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations
|
Phase 2 | |
Completed |
NCT03462680 -
GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures
|
N/A | |
Completed |
NCT02837172 -
Diagnosis of PD and PD Progression Using DWI
|
||
Not yet recruiting |
NCT04046276 -
Intensity of Aerobic Training and Neuroprotection in Parkinson's Disease
|
N/A | |
Recruiting |
NCT02952391 -
Assessing Cholinergic Innervation in Parkinson's Disease Using the PET Imaging Marker [18F]Fluoroethoxybenzovesamicol
|
N/A | |
Active, not recruiting |
NCT02937324 -
The CloudUPDRS Smartphone Software in Parkinson's Study.
|
N/A | |
Completed |
NCT02927691 -
Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial
|
Phase 2 | |
Completed |
NCT02874274 -
Vaccination Uptake (VAX) in PD
|
N/A |